Explore recent issues of Contract Pharma covering key industry trends.
Read the full digital version of our magazine online.
Stay informed! Subscribe to Contract Pharma for industry news and analysis.
Get the latest updates and breaking news from the pharmaceutical and biopharmaceutical industry.
Discover the newest partnerships and collaborations within the pharma sector.
Keep track of key executive moves and promotions in the pharma and biopharma industry.
Updates on the latest clinical trials and regulatory filings.
Stay informed with the latest financial reports and updates in the pharma industry.
Expert Q&A sessions addressing crucial topics in the pharmaceutical and biopharmaceutical world.
In-depth articles and features covering critical industry developments.
Access exclusive industry insights, interviews, and in-depth analysis.
Insights and analysis from industry experts on current pharma issues.
A one-on-one video interview between our editorial teams and industry leaders.
Listen to expert discussions and interviews in pharma and biopharma.
A detailed look at the leading US players in the global pharmaceutical and BioPharmaceutical industry.
Browse companies involved in pharmaceutical manufacturing and services.
Comprehensive company profiles featuring overviews, key statistics, services, and contact details.
A comprehensive glossary of terms used in the pharmaceutical and biopharmaceutical industry.
Watch in-depth videos featuring industry insights and developments.
Download in-depth eBooks covering various aspects of the pharma industry.
Access detailed whitepapers offering analysis on industry topics.
View and download brochures from companies in the pharmaceutical sector.
Explore content sponsored by industry leaders, providing valuable insights.
Stay updated with the latest press releases from pharma and biopharma companies.
Explore top companies showcasing innovative pharma solutions.
Meet the leaders driving innovation and collaboration.
Engage with sessions and panels on pharma’s key trends.
Hear from experts shaping the pharmaceutical industry.
Join online webinars discussing critical industry topics and trends.
A comprehensive calendar of key industry events around the globe.
Live coverage and updates from major pharma and biopharma shows.
Find advertising opportunities to reach your target audience with Contract Pharma.
Review the editorial standards and guidelines for content published on our site.
Understand how Contract Pharma handles your personal data.
View the terms and conditions for using the Contract Pharma website.
What are you searching for?
3115 Merryfield Row, 200, San Diego, CA, 92121, US
Resilience is a technology-focused biomanufacturing company dedicated to broadening access to complex medicines. Founded in 2020, the company is building a sustainable network of high-tech, end-to-end manufacturing solutions to ensure the treatments of today and tomorrow can be made quickly, safely, and at scale.
Marks Breyanzi’s fourth indication in Europe, adding to existing approvals for several aggressive B-cell lymphomas.
By: Charlie Sternberg
Plans an expansion of its flagship biologics manufacturing facility in Frederick and construction of a new facility in Gaithersburg.
AGC Biologics to provide GMP manufacturing for AAVantgarde’s two novel candidates designed to address progressive and irreversible vision loss.
The strategic investment will help ensure all key Novartis medicines for U.S. patients are manufactured in the U.S. and delivered to patients across the country at scale.
A conversation with Upperton’s Director of Pharmaceutical Sciences
Released By Upperton
To provide access to dedicated, fully equipped wet lab facilities and strategic scientific engagement.
By: Kristin Brooks
The collaboration will leverage AGC Biologics' mRNA manufacturing knowledge and expertise to combat a leading cause of human mortality.
Iglesias will lead global medical affairs for botensilimab (BOT) and balstilimab (BAL).
Marks a strategic milestone in Halozyme’s mission to expand its drug delivery technology offerings to biopharma companies.
Expands the company’s nationwide network supporting cell and gene therapy (CGT) innovation.
Non-exclusive license provides Solid’s proprietary, next-gen capsid, AAV-SLB101, to Andelyn Biosciences.
Tyruko (natalizumab) is the first and only biosimilar for Multiple Sclerosis.
By: Rachel Klemovitch
Over the past 20 years, the company has grown from a small startup into a trusted CDMO partner for biopharma companies worldwide.
Carlos Martin joins the company with over 20 years of leadership experience.
Save your seat for the December 2nd webinar from Contract Pharma and Samsung Biologics.
Released By Samsung Biologics
Enter the destination URL
Or link to existing content
Enter your account email.
A verification code was sent to your email, Enter the 6-digit code sent to your mail.
Didn't get the code? Check your spam folder or resend code
Set a new password for signing in and accessing your data.
Your Password has been Updated !
